The nurse caring for a client prescribed clozapine reviews the client's laboratory studies. Which laboratory study is the priority to monitor for an adverse effect associated with the use of this medication?

Appeared in: NORCET 5 Prelims - Sept 2023 (Shift-2)

Explanation

Clozapine carries a significant risk of causing agranulocytosis, a life-threatening condition where the body has an extremely low number of white blood cells, specifically neutrophils.
This severe drop in WBCs cripples the immune system, leaving the client highly vulnerable to overwhelming and potentially fatal infections.
Due to this high risk, regulatory bodies mandate strict monitoring of the White Blood Cell (WBC) count and/or Absolute Neutrophil Count (ANC) before initiating and throughout the course of therapy.
This makes monitoring the WBC count the highest and most immediate priority to ensure patient safety.

Option A: While clozapine can rarely cause thrombocytopenia (low platelets), its primary and most dangerous hematological effect is on white blood cells. Monitoring platelets is not the priority.
Option B: Clozapine and other atypical antipsychotics can cause metabolic syndrome, leading to elevated cholesterol. While this requires monitoring, it is a chronic, long-term concern and not an acute, life-threatening priority like agranulocytosis.
Option C: Blood urea nitrogen (BUN) is a measure of kidney function. Clozapine's primary and most feared toxicity is not renal; it is hematological. Therefore, monitoring BUN is not the priority.

Visual 1: Flowchart: Clozapine Monitoring Protocol. A visual guide showing the required frequency of WBC/ANC monitoring (weekly for 6 months, bi-weekly for 6 months, then monthly) and the action thresholds for low counts, illustrating when to hold or discontinue the medication.

Clinical Relevance

Nursing practice connection: Use the key finding related to Priority laboratory monitoring for clozapine adverse effects to guide bedside assessment, documentation, and the next nursing action.
Nurses are integral to the Clozapine REMS (Risk Evaluation and Mitigation Strategy) program. This involves ensuring blood draws are performed on schedule and verifying that the WBC/ANC results are within the acceptable range before dispensing each dose of the medication.
Patient education is a critical nursing responsibility. The nurse must teach the client and family to immediately report any signs of infection, such as fever, sore throat, chills, or weakness, as these could be the first signs of life-threatening agranulocytosis.
What if? If a client on clozapine calls the clinic to report a new-onset fever and sore throat, the nurse's priority action is to instruct the client to hold the next dose of clozapine and seek immediate medical attention for a STAT WBC/ANC count, while also notifying the prescriber.

How to Approach the Question

First, identify the key words in the question stem: 'clozapine' and 'priority laboratory study'. The word 'priority' is crucial, as it asks for the most important monitoring parameter.
Access your knowledge of psychopharmacology. Recall that clozapine is a unique antipsychotic with a significant black box warning.
Think about the most severe, life-threatening adverse effect associated with clozapine. This is agranulocytosis.
Evaluate the options in the context of this life-threatening effect. Agranulocytosis is a condition involving white blood cells.
Compare this to the other options: Platelet count (clotting), Cholesterol (metabolic), and BUN (kidney function) are not related to the primary, acute danger of clozapine.
Conclude that the WBC count is the laboratory study that directly monitors for clozapine's most dangerous adverse effect, making it the highest priority.

Concept Tested & Keywords

Q1XM4wfkhgEQVtqIum-trV

Practise the full NORCET 5 Prelims - Sept 2023 (Shift-2)

Attempt every question from this paper in a timed mock, then review the full solution for each one.